The United States Food and Drug Administration (FDA) establishes regulations for electronic records and signatures in Title 21 CFR Part 11 of the Code of Federal Regulations.

Effective since 1997 and updated several times since, Part 11 applies to industries regulated by the FDA such as pharmaceuticals, biotechs, CROs, and medical device manufacturers.